A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 7, 1996, Pages 733-739

  McMahon, Brian J ^a   Beller, Michael ^b   Williams, James ^a   Schloss, Mindy ^b   Tanttila, Harvey ^a   Bulkow, Lisa ^c  

^a ALASKA NATIVE MEDICAL CENTER   (United States)

^b Dept of Health and Social Services   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M ANTIBODY;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL TRIAL; DRUG INDUCED DISEASE; ERYTHEMA; FATIGUE; FEVER; HEALTH PROGRAM; HEPATITIS A; HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RURAL POPULATION; UNITED STATES; VACCINATION;

EID: 0029900124     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170320079014     Document Type: Article

References (18)

1. Middaugh J. Epidemiology Office, State of Alaska, Infectious Disease Data. Anchorage, Ala: State of Alaska; 1987:283-311.
2. Middaugh J, ed. Hepatitis A: statewide outbreak continues. State Alaska Epidemiol Bull. 1988;24:1.
3. Middaugh J, ed. Hepatitis A continues rural spread. State Alaska Epidemiol Bull. 1992;27:1.
4. Andre FE, Hepburn A, O'Hondt E. Inactivated candidate vaccines for hepatitis A. Prog Med Virol. 1990;37:72-95.
5. Tilzey AJ, Palmer SJ, Barrow S, et al. Clinical trial with inactivated hepatitis vaccine and recommendations for its use. BMJ. 1992;304:1272-1276.
6. Lee SD, Lo KJ, Chan CY, Yu MY, Wang YJ, Safary A. Immunogenicity of inactivated hepatitis A vaccine in children. Gastroenterology. 1993;104:1129-1132.
7. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis J. 1993;12:359-362.
8. Nalin D, Brown L, Kuter B, et al. Inactivated hepatitis A vaccine in childhood: implications for disease control. Vaccine. 1993;11:515-517.
9. McMahon BJ, Williams J, Bulkow L, et al. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults. J Infect Dis. 1995;171:676-679.
10. Scheifele DW, Bjornson GJ. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more. Can Med Assoc J. 1993;148:551-555.
11. Werzberger A, Mensch B, Kuter B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med. 1992;327: 453-457.
12. Innis BL, Snitbhan R, Kunasol P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA. 1994;271:1328-1334.
13. McMahon BJ, Rhoades ER, Heyward WL, et al. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaska Natives. Lancet. 1987;2:1134-1136.
14. Bulkow LR, Wainwright RB, McMahon BJ, Middaugh JP, Jenkerson SA, Margolis HS. Secular trends in hepatitis A virus infection among Alaska Natives. J Infect Dis. 1993;168:1017-1020.
15. Winokur PL, Stapleton JT. Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis. 1992;14:580-586.
16. Andre FE. Development of a vaccine against hepatitis A. In: Hollinger FB, Lemon SM, Margolis HS, eds, Viral Hepatitis and Liver Disease. Baltimore, Md: Williams & Wilkins; 1991:85-88.
17. Green MS, Cohen D, Lerman Y, et al. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis. 1993;168:740-743.
18. McMahon BJ, Shapiro CN, Robertson BA. Hepatitis A. In: Haubrich W, Shaffner F, Berk JE, eds. Bockus Gastroenterology. 5th ed. Philadelphia, Pa: WB Saunders Co; 1994:2044-2061.